{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T16:46:10Z","timestamp":1775666770093,"version":"3.50.1"},"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T00:00:00Z","timestamp":1210118400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002124","type":"journal-article","created":{"date-parts":[[2008,5,6]],"date-time":"2008-05-06T18:49:27Z","timestamp":1210099767000},"page":"e2124","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine \u2014 A Novel Immunotherapeutic Strategy"],"prefix":"10.1371","volume":"3","author":[{"given":"Nina","family":"Movsesyan","sequence":"first","affiliation":[]},{"given":"Anahit","family":"Ghochikyan","sequence":"additional","affiliation":[]},{"given":"Mikayel","family":"Mkrtichyan","sequence":"additional","affiliation":[]},{"given":"Irina","family":"Petrushina","sequence":"additional","affiliation":[]},{"given":"Hayk","family":"Davtyan","sequence":"additional","affiliation":[]},{"given":"Purevdorj B.","family":"Olkhanud","sequence":"additional","affiliation":[]},{"given":"Elizabeth","family":"Head","sequence":"additional","affiliation":[]},{"given":"Arya","family":"Biragyn","sequence":"additional","affiliation":[]},{"given":"David H.","family":"Cribbs","sequence":"additional","affiliation":[]},{"given":"Michael G.","family":"Agadjanyan","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2008,5,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis.","volume":"256","author":"JA Hardy","year":"1992","journal-title":"Science"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide.","volume":"8","author":"C Haass","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/22124","article-title":"Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse [see comments].","volume":"400","author":"D Schenk","year":"1999","journal-title":"Nature"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/35050110","article-title":"A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.","volume":"408","author":"C Janus","year":"2000","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/35050116","article-title":"A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.","volume":"408","author":"D Morgan","year":"2000","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nn842","article-title":"Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.","volume":"5","author":"JC Dodart","year":"2002","journal-title":"Nat Neurosci"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/78682","article-title":"Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease.","volume":"6","author":"F Bard","year":"2000","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0896-6273(03)00294-0","article-title":"Antibodies against beta-Amyloid Slow Cognitive Decline in Alzheimer's Disease.","volume":"38","author":"C Hock","year":"2003","journal-title":"Neuron"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1750-3639.2004.tb00493.x","article-title":"Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease.","volume":"14","author":"I Ferrer","year":"2004","journal-title":"Brain Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm840","article-title":"Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report.","volume":"9","author":"JA Nicoll","year":"2003","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000073623.84147.A8","article-title":"Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization.","volume":"61(1)","author":"JM Orgogozo","year":"2003","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1212\/01.WNL.0000148590.39911.DF","article-title":"Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease.","volume":"64","author":"E Masliah","year":"2005","journal-title":"Neurology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1212\/01.WNL.0000148604.77591.67","article-title":"Evaluation of the safety and immunogenicity of synthetic Abeta42 (AN1792) in patients with AD.","volume":"64","author":"AJ Bayer","year":"2005","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.2353\/ajpath.2006.060269","article-title":"Amyloid-beta peptide remnants in AN-1792-immunized Alzheimer's disease patients: a biochemical analysis.","volume":"169","author":"RL Patton","year":"2006","journal-title":"Am J Pathol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1097\/01.jnen.0000240466.10758.ce","article-title":"Abeta species removal after abeta42 immunization.","volume":"65","author":"JA Nicoll","year":"2006","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nrn938","article-title":"Opinion: Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning.","volume":"3","author":"D Schenk","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2174\/1573395054065179","article-title":"Immunotherapy for Alzheimer's Disease: Potential Problems and Possible Solutions.","volume":"1","author":"DH Cribbs","year":"2005","journal-title":"Current Immunology Reviews"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/rej.2006.9.77","article-title":"Amyloid-beta immunotherapy for the prevention and treatment of Alzheimer disease: lessons from mice, monkeys, and humans.","volume":"9","author":"CA Lemere","year":"2006","journal-title":"Rejuvenation Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4049\/jimmunol.174.3.1580","article-title":"Prototype Alzheimer's disease vaccine using the immunodominant B cell epitope from beta-amyloid and promiscuous T cell epitope pan HLA DR-binding peptide.","volume":"174","author":"MG Agadjanyan","year":"2005","journal-title":"J Immunol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"22376","DOI":"10.1074\/jbc.M700088200","article-title":"Anti-Abeta 1\u201311 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils, but not the most toxic oligomers.","volume":"282","author":"G Mamikonyan","year":"2007","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1523\/JNEUROSCI.3201-07.2007","article-title":"Alzheimer's Disease Peptide Epitope Vaccine Reduces Insoluble But Not Soluble\/Oligomeric A{beta} Species in Amyloid Precursor Protein Transgenic Mice.","volume":"27","author":"I Petrushina","year":"2007","journal-title":"J Neurosci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides.","volume":"1","author":"J Alexander","year":"1994","journal-title":"Immunity"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/j.vaccine.2005.11.039","article-title":"Prototype Alzheimer's disease epitope vaccine induced strong Th2-type anti-Abeta antibody response with Alum to Quil A adjuvant switch.","volume":"24","author":"A Ghochikyan","year":"2006","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1002\/eji.200324000","article-title":"Generation and chracterization of the humoral immune response to DNA immunization with a chimeric \u03b2-amyloid-interleukin-4 minigene.","volume":"33","author":"A Ghochikyan","year":"2003","journal-title":"Eur J Immunol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1001\/archneur.61.12.1859","article-title":"Gene vaccination to bias the immune response to amyloid-beta peptide as therapy for Alzheimer disease.","volume":"61","author":"B Qu","year":"2004","journal-title":"Arch Neurol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00109-004-0570-z","article-title":"Antibodies from a DNA peptide vaccination decrease the brain amyloid burden in a mouse model of Alzheimer's disease.","volume":"82","author":"JG Schultz","year":"2004","journal-title":"J Mol Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"4630","DOI":"10.1016\/j.vaccine.2005.08.036","article-title":"Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice.","volume":"24","author":"MA Kutzler","year":"2006","journal-title":"Vaccine"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.imlet.2007.06.006","article-title":"Enhancing Th2 immune responses against amyloid protein by a DNA prime-adenovirus boost regimen for Alzheimer's disease.","volume":"112","author":"HD Kim","year":"2007","journal-title":"Immunol Lett"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1182\/blood-2002-01-0086","article-title":"DNA vaccines encoding human immunodeficiency virus-1 glycoprotein 120 fusions with proinflammatory chemoattractants induce systemic and mucosal immune responses.","volume":"100","author":"A Biragyn","year":"2002","journal-title":"Blood"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.4049\/jimmunol.167.11.6644","article-title":"Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens.","volume":"167","author":"A Biragyn","year":"2001","journal-title":"J Immunol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"10273","DOI":"10.1073\/pnas.191118298","article-title":"Immune hyporespobnsivness to amyloid b-peptide in amyloid precursor protein transgenic mice: mplications for the pathogenesis and treatment of Alzheimer's disease.","volume":"98","author":"A Monsonego","year":"2001","journal-title":"Proc Nat Acad Sci, USA,"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(02)01357-5","article-title":"Importance of IgG2c isotype in the immune response to b-amyloid in APP\/Tg mice.","volume":"338","author":"I Petrushina","year":"2003","journal-title":"Neurosci Letters"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1471-2202-8-22","article-title":"Improvement of a low pH antigen-antibody dissociation procedure for ELISA measurement of circulating anti-Abeta antibodies.","volume":"8","author":"Q Li","year":"2007","journal-title":"BMC Neurosci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaut.2007.07.006","article-title":"Auto-reactive B cells in transgenic mice.","volume":"29","author":"JL Pasquali","year":"2007","journal-title":"J Autoimmun"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production.","volume":"236","author":"CM Snapper","year":"1987","journal-title":"Science"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.","volume":"45","author":"LM Billings","year":"2005","journal-title":"Neuron"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer's disease and related disorders.","volume":"8","author":"C Ballatore","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1126\/science.1058189","article-title":"Enhanced Neurofibrillary Degeneration in Transgenic Mice Expressing Mutant Tau and APP.","volume":"293","author":"J Lewis","year":"2001","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.","volume":"24","author":"S Oddo","year":"2003","journal-title":"Neurobiol Aging"},{"key":"ref40","article-title":"Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles.","author":"S Oddo","year":"2006","journal-title":"J Biol Chem"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.1078259","article-title":"Cerebral hemorrhage after passive anti-Abeta immunotherapy.","volume":"298","author":"M Pfeifer","year":"2002","journal-title":"Science"},{"key":"ref42","article-title":"Amyloid-b vaccination, but not nitro-NSAID treatment, increases vascular amyloid and microhemorrhage while both reduce parenchymal amyloid.","author":"DM Wilcock","year":"2007","journal-title":"Neuroscience"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1523\/JNEUROSCI.3710-06.2007","article-title":"Active beta-amyloid immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid.","volume":"27","author":"G Chen","year":"2007","journal-title":"J Neurosci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1084\/jem.187.1.129","article-title":"Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.","volume":"187","author":"R Bonecchi","year":"1998","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.187.6.875","article-title":"Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes.","volume":"187","author":"F Sallusto","year":"1998","journal-title":"J Exp Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","article-title":"Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.","volume":"11","author":"T Imai","year":"1999","journal-title":"Int Immunol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.4049\/jimmunol.169.5.2337","article-title":"Enhancement of MHC class II-restricted responses by receptor-mediated uptake of peptide antigens.","volume":"169","author":"L Zaliauskiene","year":"2002","journal-title":"J Immunol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1182\/blood-2004-02-0637","article-title":"Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo.","volume":"104","author":"A Biragyn","year":"2004","journal-title":"Blood"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1182\/blood-2005-08-3207","article-title":"Chemokine receptor targeting efficiently directs antigens to MHC class I pathways and elicits antigen-specific CD8+ T-cell responses.","volume":"107","author":"R Schiavo","year":"2006","journal-title":"Blood"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/35105075","article-title":"Strategies for designing and optimizing new generation vaccines.","volume":"1","author":"JA Berzofsky","year":"2001","journal-title":"Nature Rev Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.0600966103","article-title":"Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety.","volume":"103","author":"Y Okura","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1172\/JCI200318104","article-title":"Increased T cell reactivity to amyloid beta protein in older humans and patients with Alzheimer disease.","volume":"112(3)","author":"A Monsonego","year":"2003","journal-title":"J Clin Invest"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/intimm\/dxg049","article-title":"Adjuvant-dependent modulation of Th1 and Th2 responses to immunization with beta-amyloid.","volume":"15","author":"DH Cribbs","year":"2003","journal-title":"Int Immunol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,11]],"date-time":"2019-05-11T00:36:46Z","timestamp":1557535006000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002124"}},"subtitle":[],"editor":[{"given":"Joseph El","family":"Khoury","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2008,5,7]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,5,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002124","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,7]]}}}